Analyst Ratings for Moleculin Biotech (MBRX)

MBRX Rating Summary

  |   Expand Research on MBRX
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/9/2025 H.C. Wainwright
» Updated 9/10/2025		 Sara Nik New Coverage Buy
(N/A)		 4.00
(N/A)		 0.67
(0.83)		 23.88% Details
3/25/2025 Maxim Group Jason McCarthy Upgrade Buy
(Hold)		 4.00
(N/A)		 1.06
(0.83)		 -21.7% Details